Elicio Therapeutics's total assets for Q4 2025 were $25.86M, a decrease of -8.56% from the previous quarter. ELTX total liabilities were $24.23M for the fiscal quarter, a -0.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.